The Opioid Crisis and the Crucial Role of State Executives

The opioid epidemic remains one of the most devastating public health emergencies in modern American history, claiming tens of thousands of lives annually and straining healthcare systems, law enforcement, and communities. While federal agencies provide funding and broad guidelines, the front lines of the response are managed by state governments. State executives—governors, lieutenant governors, attorneys general, and health commissioners—wield significant authority to shape policies that directly affect opioid prescribing, addiction treatment, harm reduction, and law enforcement. Their decisions determine how effectively resources are deployed, how laws are written and enforced, and how quickly evidence-based interventions reach those in need.

This article explores the vital role state executives play in addressing the opioid crisis, the key policy strategies they employ, the obstacles they face, and real-world examples of successful state-led initiatives. By understanding these dynamics, stakeholders can better advocate for and implement policies that save lives and reduce the long-term impact of the epidemic.

The Role of State Executives in Combating the Opioid Epidemic

State executives are uniquely positioned to coordinate multi-agency responses that span health departments, Medicaid offices, substance use disorder treatment systems, law enforcement agencies, and education systems. They set the tone for how their states approach addiction—whether as a criminal justice issue, a public health challenge, or a combination of both. Their executive orders, budget proposals, and legislative agendas can accelerate or hinder the adoption of proven strategies.

For example, governors have the power to declare a public health emergency, which can unlock flexible funding and expedite regulatory waivers. They can also appoint task forces, direct state agencies to prioritize naloxone distribution, and negotiate with health insurers to remove barriers to medication-assisted treatment (MAT). Attorneys general, meanwhile, often lead multistate litigation against pharmaceutical manufacturers and distributors, recovering billions of dollars that can fund addiction services. State health commissioners oversee prescription drug monitoring programs (PDMPs) and data-sharing initiatives that track opioid prescribing patterns.

Because the opioid crisis evolves quickly—from prescription opioids to heroin to fentanyl and now to xylazine adulterants—state executives must constantly adapt their approaches. Their leadership is essential for maintaining momentum and ensuring that policies remain aligned with the latest evidence and emerging threats.

Key Policy Strategies Employed by State Leaders

State executives have implemented a wide range of policy strategies to reduce opioid misuse, prevent overdoses, and expand access to care. While no single approach works in isolation, the following areas have proven most impactful.

Expanding Access to Treatment and Medication-Assisted Recovery

One of the most effective tools against opioid use disorder (OUD) is medication-assisted treatment (MAT), which includes methadone, buprenorphine, and naltrexone. Many governors have prioritized expanding MAT capacity by increasing funding for clinics, reducing prior authorization requirements, and supporting mobile treatment units. Several states have also expanded Medicaid under the Affordable Care Act, providing coverage for addiction treatment to low-income adults. Research shows that states that expanded Medicaid saw significant increases in MAT use and reductions in overdose deaths.

State executives have also worked to remove regulatory barriers. For instance, some have waived the requirement for a separate waiver to prescribe buprenorphine (the so-called "X-waiver"), a step later mirrored by federal policy. Others have invested in telehealth services, allowing patients in rural areas to access addiction specialists remotely. Additionally, governors have championed "hub-and-spoke" models, where specialized addiction treatment centers (hubs) coordinate with primary care providers (spokes) to offer continuous care.

Enhancing Prescription Drug Monitoring Programs (PDMPs)

PDMPs are state-level electronic databases that track controlled substance prescriptions. When used effectively, they help clinicians identify patients who may be doctor-shopping or receiving dangerous combinations of opioids and benzodiazepines. State executives have strengthened PDMPs by mandating prescriber queries, integrating data with electronic health records, and making the systems interoperable across state lines. Some states have also required that PDMPs be checked before prescribing opioids for acute pain (e.g., after dental procedures) to reduce the risk of misuse.

Innovative state executives have also used PDMP data to target high-risk prescribers, send prescriber feedback reports, and identify communities with above-average opioid prescribing rates for targeted interventions. However, challenges remain in ensuring that PDMPs are user-friendly, up-to-date, and not overly burdensome for clinicians.

Supporting Harm Reduction Initiatives

Harm reduction strategies have gained increasing acceptance as a critical component of the opioid response. State executives have played a key role in expanding access to naloxone, a life-saving medication that reverses opioid overdoses. Many have issued standing orders allowing pharmacies to dispense naloxone without a prescription, funded community-based naloxone distribution programs, and trained first responders and family members in its use.

Some states have gone further by establishing syringe service programs (SSPs), which provide sterile injection equipment, reduce HIV and hepatitis C transmission, and offer opportunities to connect people with treatment. A handful of states have also piloted supervised consumption sites, where individuals can use drugs under medical supervision to prevent fatal overdoses. While these initiatives remain politically controversial, state executives in places like Rhode Island, New York, and California have pushed them forward as evidence-based public health measures.

Legislative Reforms and Criminal Justice Approaches

State executives influence legislation that can reshape how opioid-related offenses are prosecuted and how individuals with addiction are treated within the criminal justice system. Several governors have signed "Good Samaritan" laws that grant limited immunity from prosecution for individuals who call 911 during an overdose. Others have supported "360-degree" programs that divert low-level drug offenders into treatment instead of incarceration.

Additionally, state executives have worked to reform prescribing laws, such as limiting the duration and dosage of initial opioid prescriptions for acute pain. Many states now require prescribers to offer alternative pain management options and discuss risks with patients. At the same time, attorneys general have pursued landmark legal settlements, including the $26 billion opioid settlement with Johnson & Johnson and distributors, which provides states with funds for addiction services.

Challenges Faced by State Executives

Despite their best efforts, state leaders confront formidable challenges that complicate the fight against the opioid crisis.

Limited and Unpredictable Funding

Much of the funding for opioid response comes from federal grants, such as the State Opioid Response (SOR) grants administered by SAMHSA. However, these grants are often time-limited and subject to political shifts. State executives must also compete with other budget priorities—education, infrastructure, healthcare—making it difficult to sustain long-term prevention and treatment programs. The opioid settlement money, while substantial, is often disbursed over many years and may come with restrictions that limit how quickly it can be deployed.

Stigma and Political Opposition

Addiction remains highly stigmatized, and many state executives face pushback when proposing harm reduction measures like SSPs or supervised consumption sites. Opposition from local communities, law enforcement, and conservative constituencies can block or delay implementation. Even evidence-based treatment expansions may be viewed as "enabling" drug use by segments of the public, forcing state leaders to invest heavily in public education campaigns.

Balancing Public Health and Law Enforcement

State executives must navigate the tension between treating addiction as a health issue and cracking down on illegal drug supply. Overly punitive approaches can deter people from seeking help, while overly lenient policies may be perceived as ineffective against traffickers. Finding the right balance is difficult, especially in states with limited resources and high rates of violent crime linked to drug markets.

Data Sharing and Interoperability

Effective opioid policy relies on accurate, timely data. However, state health departments, Medicaid agencies, PDMP systems, and law enforcement often operate in silos with incompatible databases. Privacy laws like HIPAA can also impede information sharing. State executives need to invest in health information exchanges and cross-agency data integration to track outcomes and identify emerging crises (e.g., spikes in fentanyl deaths).

Rural and Urban Disparities

The opioid crisis affects both urban and rural communities, but the challenges differ. Rural areas often lack addiction treatment providers, harm reduction services, and public transportation to appointments. Urban areas face higher concentrations of fentanyl and synthetic drugs, as well as greater homelessness and co-occurring mental illness. State executives must tailor policies to these distinct settings—a one-size-fits-all approach rarely works.

Overcoming Challenges Through Innovation and Collaboration

Despite these obstacles, many state executives have demonstrated remarkable creativity and determination. They have forged cross-state compacts to share best practices, partnered with nonprofits like the National Governors Association’s opioid initiative, and engaged directly with communities affected by addiction. Some have appointed "opioid czars" to coordinate the response across agencies and ensure that funding is spent effectively.

Technology also offers new possibilities. Several states are using machine learning to predict overdose hotspots and target naloxone distribution. Others have deployed mobile apps that connect individuals with treatment slots in real time. State executives who embrace such innovations can achieve better outcomes with limited resources.

Case Studies: Successful State Initiatives

Examining specific states provides valuable lessons for what works—and what doesn't—in opioid policy.

Ohio: A Comprehensive, Data-Driven Response

Ohio has been at the epicenter of the opioid crisis, with overdose death rates among the highest in the nation. In response, Governor Mike DeWine launched the "Ohio Opioid Response" in 2019, allocating over $200 million from the state budget and federal grants. Key initiatives include expanding access to buprenorphine in emergency departments, funding mobile health units that reach rural Appalachia, and creating a statewide "opioid dashboard" to track deaths, prescriptions, and treatment capacity. The state also invested heavily in naloxone distribution and partnered with law enforcement to refer individuals to treatment instead of jail. As a result, overdose deaths in Ohio decreased by 4% in 2021 and by another 5% in 2022, according to preliminary data.

Rhode Island: Integrating Harm Reduction and Treatment

Rhode Island has taken a bold approach by integrating harm reduction into its mainstream health system. Under Governor Gina Raimondo and later Governor Dan McKee, the state funded a pioneering supervised consumption site pilot—the first in the nation—and expanded its syringe service programs to include fentanyl test strips and wound care. Rhode Island also implemented a "hub and spoke" treatment model that significantly increased the number of people receiving MAT. By 2023, the state reported a 12% reduction in overdose fatalities compared to the prior year.

West Virginia: Tackling Rural Barriers

West Virginia has the highest opioid overdose death rate in the country, but state executives have taken aggressive steps to address rural access gaps. Governor Jim Justice expanded the state's Medicaid program to cover MAT and used federal grant money to create "quick response teams" that visit overdose survivors in their homes. The state also launched a telehealth platform that connects rural residents with addiction specialists at West Virginia University. While challenges persist, the initiatives have helped stabilize overdose death numbers and increased treatment enrollment by 15% in two years.

Future Directions for State Executive Action

The opioid crisis continues to evolve, with the rise of fentanyl-laced counterfeit pills, xylazine (a veterinary tranquilizer), and polysubstance use. State executives must stay ahead of these trends. Future priorities should include:

  • Investing in real-time surveillance systems that can detect emerging adulterants and trigger public health alerts.
  • Scaling up contingency management (incentive-based treatment) for stimulant and polysubstance use disorders, backed by research showing its effectiveness.
  • Expanding the addiction workforce by funding training for peer recovery specialists, nurse practitioners, and physician assistants to prescribe MAT.
  • Adopting universal screening for substance use disorder in primary care, emergency departments, and prenatal clinics.
  • Strengthening cross-state collaboration on prescription monitoring and law enforcement data sharing to disrupt drug trafficking networks.

Governors and their teams should also continue leveraging legal settlements to create dedicated, long-term funding streams for addiction services—preventing the money from being diverted to general budgets. Public education campaigns that humanize addiction and reduce stigma remain essential to building broad public support.

Conclusion

State executives are the linchpins of America's response to the opioid crisis. Their authority over health systems, budgets, and legislation gives them a unique ability to translate evidence into action, save lives, and mitigate the social and economic devastation caused by addiction. While challenges such as funding constraints, stigma, and political opposition persist, the innovative and determined leadership shown in states like Ohio, Rhode Island, and West Virginia demonstrates that progress is possible.

As the epidemic continues to evolve, sustained commitment from state executives—along with partnerships with federal agencies, local communities, and healthcare providers—will be essential. The goal is not just to reduce overdose deaths, but to build a comprehensive, compassionate, and resilient system that prevents addiction and supports recovery for all Americans.

For more information, see the CDC's National Drug Overdose Surveillance, the National Governors Association Opioid Initiative, and NPR’s tracking of state opioid settlement funds.